European equities traded in the US as American depositary receipts were advancing on Thursday morning, up 0.5% to 1,346.74 on the S&P Europe Select ADR Index. From continental Europe, the gainers were ...
Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £155.58. The ...
LONDON - Autolus Therapeutics plc (NASDAQ:AUTL), a biopharmaceutical company specializing in T cell therapies for cancer, has announced its participation in the upcoming 2025 Tandem Meetings | ...
Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”, the "Company”), a biopharmaceutical company committed to redefining the ...
Autolus Therapeutics (AUTL) announces an oral presentation and three poster presentations accepted to the 2025 Tandem Meetings ...
LONDON, Jan. 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces ...